NFKB1 and malaria: Although artesunate remains the first-line treatment for severe malaria owing to its rapid parasiticidal action, recent studies have shown that it also exerts immunomodulatory effects, likely through NF-κB pathway suppression, reduction of pro-inflammatory cytokine production, and attenuation of leukocyte-endothelial interactions [87].